Skip to main content
. Author manuscript; available in PMC: 2017 Dec 19.
Published in final edited form as: Microbiol Spectr. 2017 Sep;5(5):10.1128/microbiolspec.BAD-0009-2016. doi: 10.1128/microbiolspec.BAD-0009-2016

Table 1.

Stratification of disease severity associated with C. difficile colonization (44, 45).

Classification Diagnostic criteria
Asymptomatic carriage/colonization
  • Positive identification of C. difficile (toxigenic or non-toxigenic) without clinical symptoms

Mild to moderate C. difficile infection (CDI)
  • ≥3 unformed stools in 24 hours

  • Positive identification of toxigenic C. difficile

  • White blood cell (WBC) count <15,000 and serum creatinine levels <1.5X pre-morbid level

Severe CDI
  • Positive identification of toxigenic C. difficile and/or evidence of pseudomembranous colitis

  • White blood cell (WBC) count ≥15,000 cells/μl, serum albumin <3 g/dl and/or serum creatinine level ≥1.5X premorbid level

Severe, complicated CDI (sometimes referred to as “fulminant”) (45)
  • Hypotension, shock, ileus, or megacolon

  • Other systemic signs of severe infection (145) including:

    • Admission to intensive care unit

    • Altered mental status

    • Fever ≥38.5°C

    • WBC <2000 or >30,000/μl

    • Lactate >2.2 mmol/L, or

    • Evidence of end-organ damage

  • Positive identification of toxigenic C. difficile

Recurrent CDI (rCDI)
  • Recurrence of symptoms within 8 weeks of successful C. difficile treatment